decisionhealth Newsletters, Coder Pink Sheets - 2004 Issue 6 (June)
Implanted Cardiac Defibrillator Trial Shows 23% Reduction of Mortality
Subscribe or sign in to view the full article.
Article Overview
This piece covers the SCD-HeFT clinical trial and the reported mortality benefit associated with implanted cardiac defibrillators in patients with mild heart disease. It also explains the broader Medicare coverage context, including a CMS national coverage decision and the types of patients newly considered for ICD coverage. The article is relevant to coders, billers, compliance staff, and clinicians working with cardiac device reimbursement and coverage policy.
Why This Topic Matters
It helps readers understand how trial evidence and CMS coverage policy can affect reimbursement and eligibility for implanted cardiac defibrillator services.
Article Sections
-
Clinical trial results
Summarizes the trial population, treatment arms, and the reported outcome related to implanted cardiac defibrillators.
-
Medicare coverage considerations
Describes the related Medicare and CMS coverage context, including the national coverage decision and the broader patient groups being considered.
What You Will Learn
- The scope and purpose of the SCD-HeFT trial
- How the article frames the relationship between clinical evidence and ICD coverage
- The Medicare and CMS policy context discussed in the article
- Which broad patient categories are mentioned in connection with coverage expansion
Who Should Read This
- Medical coders
- Medical billers
- Compliance professionals
- Revenue cycle staff
- Cardiology clinicians
- Health policy readers
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com